Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Mar 20;12(3):826.
doi: 10.3390/nu12030826.

Neutral Human Milk Oligosaccharides Are Associated with Multiple Fixed and Modifiable Maternal and Infant Characteristics

Affiliations

Neutral Human Milk Oligosaccharides Are Associated with Multiple Fixed and Modifiable Maternal and Infant Characteristics

Meichen Wang et al. Nutrients. .

Abstract

We aimed to identify if maternal and infant factors were associated with neutral human milk oligosaccharides (HMOs) variability and examined the associations between HMOs concentration and infant growth and disease status in healthy Chinese mothers over a 6-month lactation period. We recruited mothers and their full-term infants as our subjects. At 1-5 days, 8-14 days, 4 weeks, and 6 months postpartum, all participants were interviewed to collect breast milk samples, obtain follow-up data and measure infant length and weight at their local hospital. A total of 23 neutral HMOs were analyzed by high performance liquid chromatography (HPLC)- mass spectrometer (MS). Secretor and Lewis phenotype were determined by the concentration of 2'-fucosyllactose (2'-FL) and Lacto-N-fucopentaose (LNFP)-II. The associations between maternal and infant factors with HMOs concentrations were investigated. A total of 464 human breast milk samples were collected from 116 mothers at four different time points. In total, 76.7% mothers were found to be Secretor and Lewis positive phenotype (Se+Le+), 17.2% were Se-Le+, 4.3% were Se+Le-, and 1.7% were Se-Le-. Several individual HMOs, including 2'-FL, Lactodifucotetraose (LDFT), LNFP-I were determined by Secretor phenotype. Most individual HMOs decreased at the later stage of lactation, except 3'-FL. We suggest that Secretor phenotype and lactation stage could influence most of the neutral HMOs. Concentrations of specific HMOs may be associated with maternal age, allergic history, pre-pregnancy body mass index (BMI), parity, delivery mode, infant gestational age and gender.

Keywords: human milk oligosaccharides; influenced factors; lactation stage; secretor.

PubMed Disclaimer

Conflict of interest statement

We declare that we have no financial and personal relationships with other people or organizations that can inappropriately influence our work.

Figures

Figure 1
Figure 1
Flow chart of inclusions.
Figure 2
Figure 2
Mean concentration of HMOs during different lactation periods for secretors and non-secretors, mg/L. Letters indicate if difference between Secretors and Non-Secretors is significant; a: p < 0.001, b: p < 0.05.

Similar articles

Cited by

References

    1. Gura T. Nature’s first functional food. Science. 2014;345:747–749. doi: 10.1126/science.345.6198.747. - DOI - PubMed
    1. Andreas N.J., Kampmann B., Mehring Le-Doare K. Human breast milk: A review on its composition and bioactivity. Early Hum. Dev. 2015;91:629–635. doi: 10.1016/j.earlhumdev.2015.08.013. - DOI - PubMed
    1. Thomson P., Medina D.A., Garrido D. Human milk oligosaccharides and infant gut bifidobacteria: Molecular strategies for their utilization. Food Microbiol. 2018;75:37–46. doi: 10.1016/j.fm.2017.09.001. - DOI - PubMed
    1. Le Doare K., Holder B., Bassett A., Pannaraj P.S. Mother’s Milk: A Purposeful Contribution to the Development of the Infant Microbiota and Immunity. Front. Immunol. 2018;9:361. doi: 10.3389/fimmu.2018.00361. - DOI - PMC - PubMed
    1. Lis-Kuberka J., Orczyk-Pawiłowicz M. Sialylated Oligosaccharides and Glycoconjugates of Human Milk. The Impact on Infant and Newborn Protection, Development and Well-Being. Nutrients. 2019;11:306. doi: 10.3390/nu11020306. - DOI - PMC - PubMed

Substances